Péter, L, Lázár, BA, Bajsz, A, Bőthe, B, Paksi, B, Czakó, A, Griffiths, MD ORCID: https://orcid.org/0000-0001-8880-6524, Horváth, Z, Demetrovics, Z and Andó, B,
2025.
A new scale for assessing benzodiazepine use motives among community and clinical samples: the development and validation of the MBUQ- 48.
International Journal of Mental Health and Addiction.
ISSN 1557-1874
Preview |
Text
2434629_Griffiths.pdf - Published version Download (966kB) | Preview |
Abstract
The risk for non-medical use and dependence on benzodiazepines (BZDs) is high. However, there is no available validated psychometric instrument that assesses the motives for BZD use. Therefore, the aim of the present study was to develop a scale identifying the motives for BZD use, examine the factor structure, and corroborate the construct validity of the scale. Items for the scale were generated from previous data collection and from the empirical literature. Consequently, 82 motives were tested among a large community (N = 1424) and a clinical sample (N = 113). Medical and non-medical BZD use, other substance use, and several psychological constructs were assessed in both samples. Exploratory factor analysis (EFA) and confirmatory factor analysis (CFA), as well as bivariate correlations and regression analyses, were performed. The EFA model included 48 items with four factors: “personal and interpersonal benefits”, “substance use regulation”, “coping”, and “sleep facilitation”. The four-factor CFA model demonstrated adequate levels of model fit. Members of the clinical sample had significantly higher rates of all four motives. The construct validity of the Motives for Benzodiazepine Use Questionnaire (MBUQ-48) was supported by positive correlations between the motivational factors and psychological constructs, different outcomes of BZD use, and other substance use. Coping motives had positive association with various outcomes of BZD use. Based on the results, the MBUQ-48 is a reliable and valid scale for assessing motives for BZD use. Exploring the motivations underlying BZD use can help clinicians in the recognition of the risk of BZD use disorder and in increasing the efficacy of therapeutic processes.
Item Type: | Journal article |
---|---|
Publication Title: | International Journal of Mental Health and Addiction |
Creators: | Péter, L., Lázár, B.A., Bajsz, A., Bőthe, B., Paksi, B., Czakó, A., Griffiths, M.D., Horváth, Z., Demetrovics, Z. and Andó, B. |
Publisher: | Springer Science and Business Media LLC |
Date: | 30 April 2025 |
ISSN: | 1557-1874 |
Identifiers: | Number Type 10.1007/s11469-025-01490-6 DOI 2434629 Other |
Rights: | © The Author(s) 2025. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
Divisions: | Schools > School of Social Sciences |
Record created by: | Laura Borcherds |
Date Added: | 06 May 2025 10:04 |
Last Modified: | 06 May 2025 10:04 |
URI: | https://irep.ntu.ac.uk/id/eprint/53523 |
Actions (login required)
![]() |
Edit View |
Statistics
Views
Views per month over past year
Downloads
Downloads per month over past year